Regional Brain Glucose Metabolism and Its Prognostic Value in Pretreatment Extranodal Natural Killer/T-Cell Lymphoma Patients.

Ziwei ZhouZhe GuoQingqiao HuWei DingChongyang DingLijun Tang

Published in: OncoTargets and therapy (2021)

Pretreatment stage I/II ENKTL patients exhibited abnormal regional cerebral glucose metabolism. Higher pretreatment glucose metabolism in BGT could predict a relatively poor prognosis but did not surpass the predictive values of ECOG and PINKE in stage I/II ENKTL patients.

Keyphrases

end stage renal disease
poor prognosis
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
white matter
brain injury
blood brain barrier